SCHEMBL30467656

SCHEMBL30467656

COc1ccc(CNc2cnnc3cc(-c4cc(Cl)ccc4OC(F)(F)C(F)F)ccc23)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
CYP1A2 P05177 14/20 0.38
CYP3A4 P08684 14/20 0.38
CYP2C19 P33261 13/20 0.38
TSHR P16473 11/20 0.38
CYP2C9 P11712 11/20 0.38
LMNA P02545 8/20 0.38
ALDH1A1 P00352 8/20 0.38
HSD17B10 Q99714 8/20 0.38
CLK4 Q9HAZ1 5/20 0.38
CYP2D6 P10635 12/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 3/20 0.37
GAA P10253 1/20 0.36
USP2 O75604 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252909 1.00 CNR1 (0.41) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24252485 0.92 CNR1 (0.40) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL30451966 0.92 CNR1 (0.40) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL30451317 0.90 CYP1A2 (0.46) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24252808 0.90 CYP1A2 (0.46) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24252427 0.90 CNR1 (0.40) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL30467755 0.90 CNR1 (0.40) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24253053 0.90 CNR1 (0.40) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL24252832 0.90 CNR1 (0.42) CNR1CNR2CYP1A2CYP3A4CYP2C19
SCHEMBL30451405 0.90 CNR1 (0.42) CNR1CNR2CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 EP disclosed